Agilent launches S540MD slide scanner system
March 2026—Agilent Technologies launched the Agilent S540MD slide scanner system, a whole slide imaging digital scanner available for sale in select European markets.
Webinars and Sponsored Roundtables — Register Now
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace
Zepto launches plasma-based FungiFlex Mold panel
March 2026—Zepto Life Technology has launched the FungiFlex Mold panel.
ASI acquires ELISA product line
March 2026—Arlington Scientific has completed its acquisition of Awareness Technology’s EIA/ELISA product line.
FDA clears Copan PhenoMatrix software
March 2026—Copan Group’s PhenoMatrix, an automated image assessment software used with the company’s WASPLab laboratory automation platform, received FDA 510(k) clearance as a class II device.
MRC Holland releases NXtec carrier panel
March 2026—MRC Holland launched the NXtec D028 Carrier Panel 1, a novel, DigitalMLPA assay for reliable carrier status analysis in genomically complex regions.
Biocartis and Mayo Clinic collaborate
March 2026—Biocartis has entered into a research collaboration with Mayo Clinic to develop a rapid sample-to-answer test aiming to decrease the time to treatment for breast cancer patients.
Labcorp expands MRD testing
March 2026—Labcorp has expanded its molecular residual disease portfolio to include Labcorp Plasma Detect ID, a whole exome sequence–guided, personalized panel for patients with stages I–III breast cancer or stages I–IIIA non-small cell lung cancer, and Plasma Detect Genome, a whole genome MRD test for stage III colon cancer.
IDT unveils NGS portfolio
March 2026—Integrated DNA Technologies is releasing a suite of next-generation sequencing products that aim to tackle bottlenecks in library preparation, targeted enrichment, and whole genome analysis.
ARUP creates innovation central laboratory
March 2026—ARUP Laboratories has launched an innovation central laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners.
Henry Schein, CytoChip enter distribution agreement
March 2026—Henry Schein entered into an exclusive distribution agreement with CytoChip for CitoCBC, a 510(k)-cleared, CLIA-waived, cartridge-based CBC system. CitoCBC uses blood collected in a venous draw tube to analyze 16 parameters, including the five-part differential. Test results are available in eight minutes.